Active agent in Australian-developed nasal spray >99.5% active against the Omicron SARS-CoV-2 variant
- Written by PR Newswire
- The antiviral agent in VIRALEZE™ antiviral nasal spray, SPL7013, achieved >99.5% reduction of virus infectivity (the maximal possible reduction) against the highly contagious Omicron variant of SARS-CoV-2
- SPL7013 showed potent antiviral activity and was virucidal against the Omicron variant
- SPL7013 outperformed other antiviral agents used...
